|

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

RECRUITINGSponsored by State University of New York at Buffalo
Actively Recruiting
SponsorState University of New York at Buffalo
Started2016-10-28
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT02897908

Summary

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis
* Subjects who have been previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) but who do not have current steatosis (fat) or fibrosis scoring
* Subjects who have other known liver diseases ie: HCV

Exclusion Criteria:

* Patients less than 18 years of age
* Pregnancy
* Patients that do not want to be contacted for consideration in future research studies.
* Patients diagnosed with ascites or peritoneal dialysis
* Body mass index (BMI) ≥40

Conditions2

Disease of Liver and Bile DuctLiver Disease

Locations1 site

Conventus Medical Office Building
Buffalo, New York, 14203
Ajay Chaudhuri, MD716-907-1916achaudhu@buffalo.edu

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.